Arizona's Anti-Weed Ballot Campaign Just Gave Up. The DEA's Rescheduling Hearing Is Still Arguing Over the Wrong Question.

Three days before the July 3 deadline, the campaign trying to put a recreational-marijuana repeal measure on Arizona’s November ballot quit — 255,949 valid signatures short and, by the organizer’s own account, not particularly close. He called it “a losing battle” given federal rescheduling momentum and polling that’s stopped favoring prohibition anywhere close to a majority. Arizona dispensaries keep operating exactly as they were.

That fight is over. The one that actually matters is happening in a DEA hearing room, and it’s arguing about the wrong thing.

The DEA’s administrative hearing on moving cannabis from Schedule I to Schedule III is running now, through July 15, and Drug Policy Alliance’s Cat Packer has made the sharpest critique of it public this week: the hearing is structured around whether cannabis has accepted medical use and an acceptable safety profile — a pharmacology question — while saying nothing about the decades of arrests, convictions, and collateral consequences criminalization already produced. People are still sitting in prison, still locked out of housing and jobs by convictions, for conduct that’s legal in most states today, and a rescheduling hearing built entirely around chemistry doesn’t undo a single one of those records.

None of that means the chemistry doesn’t matter — it does, and it cuts in a direction the loudest legalization advocates don’t love to sit with either. A longitudinal study tracking 463,396 adolescents from age 13 through age 26 found past-year cannabis use in the teen years associated with roughly double the risk of later psychotic and bipolar disorders, showing up 1.7 to 2.3 years after the diagnosis-preceding use — a finding that held even after controlling for prior mental health history. High-potency products are part of why: California cannabis flower now regularly tests above 20% THC, with concentrates reaching 95%, numbers that didn’t exist when most of today’s cannabis laws were written.

So: an industry that’s functionally normalized, a scheduling hearing arguing chemistry while ignoring the people criminalization already broke, and real adolescent psychiatric risk that neither side of the rescheduling fight wants to lead with. Arizona’s repeal campaign folding doesn’t resolve any of that tension — it just confirms which direction the country has already decided to walk in. The unfinished business is what happens to the people that direction left behind.